ERIN BARTELS: Open Payments
NPI 1396053641 · DYER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,177 in 114 payments from 20 companies in 2025. Trend: 2023 $4,441 · 2024 $2,328 · 2025 $2,177
Food & beverage: $1,984Education: $193
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $403 |
| Janssen Biotech, Inc. | 10 | $339 |
| Novartis Pharmaceuticals Corporation | 12 | $277 |
| Incyte Corporation | 7 | $200 |
| UCB, Inc. | 9 | $145 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $131 |
| Regeneron Healthcare Solutions, Inc. | 4 | $101 |
| LEO Pharma Inc. | 3 | $91 |
| Lilly USA, LLC | 4 | $87 |
| PFIZER INC. | 4 | $76 |
Products named: TREMFYA, SKYRIZI, OPZELURA, COSENTYX, DUPIXENT, Bimzelx, ADBRY, EBGLYSS.
Industry payments across IN — which companies pay providers there.
